Delivery Order SPE2DB20D9761-SPE2DB22FB3LP
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order worth $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of Jakafi 10 mg tablets, a specialty pharmaceutical product, with a performance period through January 14, 2025. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a range of branded and generic prescription drugs,...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $35,321.61 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the medication Jakafi 15 mg tablets, with a completion date of August 15, 2024. This award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program,...
- The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of 60 units of the prescription drug Jakafi 15 mg tablets. This delivery order is part of a larger Indefinite Delivery Contract (IDC) worth $499,999,999 between DMS Pharmaceutical Group and the DLA, which covers a comprehensive range of...
- The U.S. government awarded a delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is for the provision of the pharmaceutical product Jakafi 10 mg tablet. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to $499,999,999, which...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract worth $11,773.87 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, which has no set-aside designation, provides for the delivery of Jakafi 15 mg tablets to support the medical supply needs of U.S. government agencies, particularly the Department of Defense. This Delivery Order is issued under DMS Pharmaceutical Group's...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $9,300.73 contract is to provide the DLA with 4,556,044,091 units of the drug Jakafi 10 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) with DMS Pharmaceutical Group that allows the DLA to issue firm fixed-price orders for a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $47,362.64 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract has an ultimate completion date of October 8, 2024 and provides for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The order is for the supply of 60 units of the 5 mg tablet form of the pharmaceutical product JAKAFI. The delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA, which allows the agency to issue delivery orders for a...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed-price delivery order contract worth $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of 60 tablets of JAKAFI 10 MG, a prescription medication, with a period of performance through June 30, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a significant single-award Indefinite Delivery Contract (IDC) with the...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $35,549.43 contract is for the delivery of the prescription drug Jakafi 5 mg tablets. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program, which covers a comprehensive range of...
- SPE2DB20D9761Indefinite Delivery Contract
- SPE2DB20D9761-SPE2DB22FB3LPDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $30,054.15 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product Jakafi 10 mg tablets. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a wide range of medications and medical supplies to support the recurring medical needs of military health facilities and VA medical centers nationwide. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with DLA under the SPE2DB program, which allows the agency to issue firm fixed-price delivery orders for pharmaceutical items through December 31, 2025. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.1k | 8/4/22 |